Johnson & Johnson (NYSE:JNJ) stock, previously labeled a slow-growth “loser” pharmaceutical play, is now hot again. Shares are up 19% since March 23. They rose almost 5% on April 14, after the company delivered a strong first quarter and said it was working on a vaccine for the novel coronavirus.
Overall, Johnson & Johnson’s reputation within the industry is sound. Its balance sheet is sound, its response to the pandemic is also sound. Its focus on public health is very sound. JNJ stock won’t make you rich. It is still a slow-growing, conservative company. But in an uncertain time, with a pandemic raging, it could be your best shelter from the storm. It is unlikely to make your portfolio ill, which in the present environment makes it a buy, especially for income investors.
Source: InvestorPlace
Related Articles:
- 8 Dividend Stocks Building A Growing Cash Stream
- How To Build
A Sustainable High Yield Portfolio
- 7 High Yield, High Risk Dividend Securities
- 5 Dividend Stocks To Buy And Hold, Not Buy And Forget
- International Diversification May Be Closer than You Think
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Many investors prefer to invest in stocks they can hold on to forever. These companies tend to offer products and services with an appeal th...
-
Mid-April and May have traditionally been the months when we see Q1 earnings and dividend announcements from our favorite dividend stocks. W...
-
I wanted to find five dividend stocks that had very high yields that appeared to be quite secure. As you know, the dividend yield ratio is c...
-
Strange but true: seniors fear death less than running out of money in retirement. Also, retirees who have constructed a nest egg have valid...
-
On Wall Street, Chris Harvey, Wells Fargo’s head of equity strategy, sees opportunities in current market conditions. “Destruction in stock ...
-
Quality items seldom go on sale, but that’s when we talk about a normal market. In a stock market that recently had its worst day since 1987...
-
Healthcare is one of the few sectors seeing high demand right now, with companies working to develop COVID-19 vaccines, treatments, and diag...
-
We’ve opened up the TipRanks database, finding three stocks whose profile justifies the entry risk in today’s unsettled conditions. All thre...
-
Stocks that pay out steady and increasing dividends are always appreciated by investors, but in times of market uncertainty and volatility, ...
-
Dividends are being cut and suspended all over the place of late, and keeping track of it all is a tall task that it likely puts many divide...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.